Abvc Biopharma (ABVC) Shares Outstanding (2010 - 2026)

Abvc Biopharma (ABVC) has reported Shares Outstanding (Entity) for 17 consecutive years, with $25.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 31.92% year-over-year to $25.8 million; the trailing twelve-month figure through Jun 2026 stood at $25.8 million (up 31.92% YoY), and the FY2025 full-year result was $20.1 million, up 45.0% from the prior year.
• Shares Outstanding (Entity) was little changed at $25.8 million in Q2 2026 per ABVC's latest filing, from $25.8 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $25.8 million in Q1 2026 and bottomed at $3.0 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $11.6 million across 5 years, with a median of $11.4 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) increased 2.39% in 2023, then surged 264.32% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $3.3 million in 2022, then soared by 31.95% to $4.3 million in 2023, then surged by 219.87% to $13.9 million in 2024, then surged by 45.0% to $20.1 million in 2025, then gained by 28.14% to $25.8 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $25.8 million, $25.8 million, and $20.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.